News

TBRS Community Patient Registry Data Are Now Available

Applications are open to TBRS Collaborative Research Network Members to access registry data!

The TBRS Community Patient Registry collects disease-specific natural history data about individuals with TBRS, with the goal of improving the understanding of TBRS and informing treatment development. Registry questionnaires were built from common data element standards and cover the following topics:

  • Socio-demographics
  • Genetics
  • Development and medical history
  • Treatment and disease progression
  • Quality of life

If you would like access to the NORD Registry data for a research project, please apply here.

The TBRS Community’s fundraising efforts have made it possible to offer Registry results at no charge to academic researchers. Your donation can help us continue to share data widely. Please consider supporting us.

TBRS Community Patient Registry Data Are Now Available Read More »

The TBRS Community is Seeking a Science Director

Description

20 hours per week, remote contract work with occasional travel, $50/hour. This is a consultant position with purpose – the chance to improve the lives of people with a rare disease. Working with our collaborative network of clinicians and scientists who study Tatton Brown Rahman Syndrome (TBRS), the Science Director will advance research toward understanding and treating TBRS. At the TBRS Community we offer a supportive, inclusive environment where staff, consultants, and volunteers can apply their talents to make a difference in others’ lives.

About Us

The TBRS Community is a nonprofit organization that supports individuals with Tatton Brown Rahman Syndrome and advances research on this rare disorder. With the ultimate goal of identifying treatments and cures for TBRS, our organization created the TBRS Community Collaborative Research Network (TBRS CRN), a group of scientists, clinicians, families, and other stakeholders who are experts on TBRS and DNMT3A (the gene that causes TBRS). The TBRS CRN members collaborate by sharing their expertise and resources with the aim of expediting treatment development for TBRS.

Our Values

The TBRS Community is committed to developing a supportive, inclusive, and collaborative network of families, clinicians, researchers, and other stakeholders. We serve the patient above all else. As a patient-led organization, we listen to our patient community, keep their priorities at the center of our work, and develop programming to support their needs. We have a compassionate culture within our community, united by our shared experience of loving people with a rare disease.

The Opportunity

As Scientific Director you will provide visionary leadership for our scientific efforts, with a focus on translational research. You will collaborate with the TBRS CRN Members to facilitate patient-focused research, identify and strengthen collaborations with academic institutions and biopharma, and identify pathways to treatment for TBRS. These efforts will chart a course along our research roadmap to ultimately result in clinical trials for TBRS. Presently, there are no therapeutic options in development for TBRS. Our CRN Members have made tremendous strides in understanding the clinical presentation of TBRS and its underlying etiology, which has positioned us to now take the next step toward pursuing therapies. The Scientific Director will lead us into this exciting new phase of research.

Click below for the full job description and application information:

Science Director Job Description 4 2023

 

The TBRS Community is Seeking a Science Director Read More »

Kit Church

Research coordinator joins TBRS Community

Kit ChurchKit Church has a background in public health genetics and experience supporting people with genetic and developmental disorders.

The TBRS Community is excited to announce that Kit Church has joined the organization as Research Coordinator. Church will work with Executive Director Jill Kiernan and Community volunteers to expand our Collaborative Research Network, organize our annual research meeting and scientific programming, and advance research in line with our families’ top priorities. She will also develop educational content and lead initiatives to fund research projects.

“We are so delighted Kit has joined our team. She has the perfect blend of skills and experiences to advocate for TBRS research and keep our families informed of the latest advances,” says Kiernan.

Church has a BS in Biology from the University of North Carolina Asheville, with a focus on genetics and mental health. During this time, she planned events to benefit autism programs through her position as Philanthropy Vice President at her sorority, Alpha Xi Delta. She has since moved to Pittsburgh, PA, with her husband Spencer and their three cats, and is currently pursuing an MPH in Public Health Genetics at the University of Pittsburgh.

Kit has known she wanted to work in the nonprofit sector for most of her life. She has worked with patients with genetic and developmental disorders for more than five years and has a real passion for helping others. She also has a background in genetic research from her undergraduate university. In her free time Kit enjoys crocheting, playing ukulele, and traveling.

Research coordinator joins TBRS Community Read More »

Doiron

TBRS researcher chosen for 2022 Young Investigator Draft

The TBRS Community is excited to announce that Karine Doiron, PhD, a postdoctoral research fellow at the Research Center of the Sainte-Justine University Hospital in Montreal, has been selected by Uplifting Athletes for its 2022 Young Investigator Draft. Dr. Doiron will receive $20,000—contributed jointly by the TBRS Community and Uplifting Athletes—to advance her research on Tatton Brown Rahman Syndrome.

“Karine has shown commitment and dedication to our community through her research and by volunteering her time at our family conference in 2021,” says Jill Kiernan, executive director of the TBRS Community. “I am so glad that she was ‘drafted’ by Uplifting Athletes and I look forward to seeing how her work improves the lives of people diagnosed with this rare disease.”

Doiron’s project will investigate the precise dysfunction in brain cells caused by variants in the DNMT3A gene, which underlies TBRS. To do this, she produces stem cells in the lab from tissue samples donated by patients. These so-called induced pluripotent stem cells are then treated to mature into different types of brain cells, and Doiron can examine which cell types derived from TBRS patients have functional differences from cells that don’t carry DNMT3A variants.

“With this support, I aim to identify and understand which specific cell types are affected during brain development of TBRS individuals,” says Doiron.

Individuals with TBRS have some degree of intellectual disability, and neuropsychiatric conditions, such as autism, are common. A survey of patients’ families determined that addressing their loved ones’ psychiatric, cognitive, and behavioral issues is a top priority. “It is so meaningful to families that we can support research into brain development, and I hope one day this will pinpoint the precise problems that we can then target for interventions,” says Kacee Richter, the president of the TBRS Community.

In its first four years, the Young Investigator Draft has awarded more than $440,000 in grant funding to 25 rare disease researchers across North America. Uplifting Athletes strives to inspire the Rare Disease Community with hope through the power of sport. The nonprofit organization, founded in 2007, engages student and professional athletes in realizing the impact of using their powerful platforms to lend a voice to the 30 million Americans diagnosed with rare diseases.

Doiron is a member of Dr. Serge McGraw’s lab. His group focuses on disruption to the ways genes are regulated—known as epigenetics—during development, such as occurs in TBRS. “Funding from the Uplifting Athletes Young Investigator Draft Grant and the TBRS Community will not only provide key information for TBRS research, but importantly, help families of afflicted individuals better comprehend the genetic, molecular, and cellular origins of TBRS,” he says. The TBRS Community is funding another project in McGraw’s lab, in partnership with the Rare Diseases Models and Mechanisms Network, to use a mouse model of TBRS to understand affected cell types and how they lead to various conditions.

Dr. Doiron will be honored along with the eight other Young Investigators on February 5, 2022, at Lincoln Financial Field in Philadelphia, PA. 

TBRS researcher chosen for 2022 Young Investigator Draft Read More »

New research opportunity: Brain-Gene Registry

Individuals with a diagnosis of Tatton Brown Rahman Syndrome are eligible to participate in the National Brain-Gene Registry, a large study aimed at understanding the consequences of genetic variants on neurodevelopment. There are 13 sites at academic medical centers and hospitals around the US collaborating on this NIH-funded study, led by Harvard University/Boston Children’s Hospital, the University of North Carolina at Chapel Hill, and Washington University School of Medicine.

Participation includes filling out a questionnaire, having a virtual visit with a study team member, and contributing some medical information, including the patient’s genetic report indicating a variant in the DNMT3A gene.

The information you contribute to the study will help researchers better understand the relationship with genetic variants and neurodevelopmental outcomes. The study is fully remote and takes a total of 2 – 3 hours to complete. They compensate participants $50 at the time of enrollment and an additional $50 after completion of the questionnaires and video visit.

Please contact Virginia at: [email protected] or call 314-620-4542 with questions or to enroll.

We are grateful to these study leaders for taking an interest in TBRS, and to all families who participate!

New research opportunity: Brain-Gene Registry Read More »

TBRS Community Receives Rare As One Grant

The TBRS Community is thrilled to announce the Chan Zuckerberg Initiative has selected our organization to be part of the Rare As One Network, a collection of ambitious, patient-led organizations that are driving progress toward understanding and treating rare diseases. The award provides $600,000 in funding over three years to support the TBRS Community’s efforts to support families, advance research, and improve diagnosis and access to resources.

“The Rare As One grant is an incredible opportunity to help us fulfill our mission to find treatments for TBRS,” said Jill Kiernan, the executive director of the TBRS Community, who founded the organization in 2017. Jill’s daughter was one of the first 13 people in the world to be diagnosed in 2014. “We have come so far in developing a truly supportive, global community of families, doctors, and researchers in a few short years, and now we will be able to push ahead at an even faster rate.”

The TBRS Community is among 50 rare disease organizations in the Rare As One Network, which launched in February 2020. In addition to financial support, the Network provides training in strengthening community, building capacity, and promoting collaboration. The Rare As One Network provides opportunities to collaborate with other rare disease organizations.

The TBRS Community advocates for individuals with Tatton Brown Rahman Syndrome, a rare disease caused by variants in the DNMT3A gene. To date, around 250 individuals have been diagnosed with TBRS globally. In 2021, the TBRS Community launched a patient registry to gather medical and developmental information into a single database that will be accessible to researchers—a much-needed resource that aims to help answer fundamental questions about the syndrome.

The TBRS Collaborative Research Network, formed in 2020, represents the world’s top clinical and scientific experts on TBRS. Driven by the priorities of our community members, the TBRS Community partners with these investigators to further research on DNMT3A and TBRS, with the ultimate goal of identifying potential interventions for TBRS.

“For biomedical research in rare diseases to advance quickly and effectively, patients must be full partners with scientists and clinicians in research,” said CZI Head of Science Cori Bargmann. “We’re proud to expand our cohort of Rare As One grantees and further support the rare disease ecosystem as we work towards diagnosis, treatments, and cures together.”

“It is an honor to be among the organizations in the Rare As One Network and to learn from each others’ accomplishments,” said Kacee Richter, the president of the TBRS Community and the mother of seven-year-old Lucas, who has TBRS. “The impact of this grant is immeasurable to patient-led organizations like ours.”

TBRS Community Receives Rare As One Grant Read More »

Translate »
Scroll to Top